259 related articles for article (PubMed ID: 29230671)
21. The treating scenario in genitourinary oncology: what is new? Part 2.
Bracarda S; Montironi R; Porta C; Szczylic C; Bearz A; Cartenì G; Bellmunt J
Future Oncol; 2013 Jun; 9(6):803-6. PubMed ID: 23718300
[TBL] [Abstract][Full Text] [Related]
22. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic targets in hematopoietic malignancies.
Claus R; Lübbert M
Oncogene; 2003 Sep; 22(42):6489-96. PubMed ID: 14528273
[TBL] [Abstract][Full Text] [Related]
24. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
Zisman A; Pantuck AJ; Belldegrun A
Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
[No Abstract] [Full Text] [Related]
25. Epigenetic drug discovery: targeting DNA methyltransferases.
Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
[TBL] [Abstract][Full Text] [Related]
26. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma.
Park HJ; Yu E; Shim YH
Cancer Lett; 2006 Feb; 233(2):271-8. PubMed ID: 15885882
[TBL] [Abstract][Full Text] [Related]
27. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
28. Present and future of personalized medicine in adult genitourinary tumors.
Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
[TBL] [Abstract][Full Text] [Related]
29. Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist.
Hwang C
Surg Pathol Clin; 2018 Dec; 11(4):877-891. PubMed ID: 30447846
[TBL] [Abstract][Full Text] [Related]
30. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
[TBL] [Abstract][Full Text] [Related]
31. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
[TBL] [Abstract][Full Text] [Related]
32. Tailoring survivorship to diverse populations with genitourinary malignancies.
Borno HT; Dixit N
Urol Oncol; 2020 Mar; 38(3):118-120. PubMed ID: 31307880
[TBL] [Abstract][Full Text] [Related]
33. Molecular biology of genitourinary cancer.
Ackermann R; Schmitz-Dräger BJ
World J Urol; 1994; 12(2):63. PubMed ID: 8087141
[No Abstract] [Full Text] [Related]
34. Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
Fu HY; Shen JZ; Wu Y; Shen SF; Zhou HR; Fan LP
Oncol Rep; 2010 Aug; 24(2):335-43. PubMed ID: 20596618
[TBL] [Abstract][Full Text] [Related]
35. Genitourinary malignancies in solid organ transplant recipients.
Muruve NA; Shoskes DA
Transplantation; 2005 Sep; 80(6):709-16. PubMed ID: 16210955
[TBL] [Abstract][Full Text] [Related]
36. Bibliography. Genitourinary system. Current world literature.
Curr Opin Oncol; 2013 May; 25(3):330-3. PubMed ID: 23667937
[No Abstract] [Full Text] [Related]
37. The role of TET family proteins and 5-hydroxymethylcytosine in human tumors.
Wu YC; Ling ZQ
Histol Histopathol; 2014 Aug; 29(8):991-7. PubMed ID: 24585390
[TBL] [Abstract][Full Text] [Related]
38. Methyl group acceptance assay for the determination of global DNA methylation levels.
Nephew KP; Balch C; Skalnik DG
Methods Mol Biol; 2009; 507():35-41. PubMed ID: 18987804
[TBL] [Abstract][Full Text] [Related]
39. Genitourinary malignancies.
Selman SH
Prim Care; 1989 Dec; 16(4):1013-30. PubMed ID: 2692040
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy for genitourinary malignancies in the here and now!
Slovin SF
Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
